Centese CEO, Evan Luxon Named Innovator Of The Year
Pipeline Inc. held its annual entrepreneurial awards gala Thursday evening, which honored several local entrepreneurs and introduced the 2018 Pipeline class members. Evan Luxon received Innovator of...
View ArticleFirst Thoraguard Study Completed at Stanford University Medical Center
Latest Guidelines to Enhance Patient Recovery after Cardiac Surgery Strongly Recommend: Maintenance of Chest Tube Patency to Prevent Complications OMAHA, Neb. – January 21, 2020 – Centese, Inc. today...
View ArticleHomegrown medtech company Centese develops game-changing device for surgery...
A new Omaha-based medtech company has developed a self-cleaning chest tube system that provides more precise measurements for monitoring patients recovering from surgery on their heart or lungs....
View ArticleStudy validates the first automated chest tube clearance system for cardiac...
Peer-reviewed clinical study shows Thoraguard® delivers effective, automated chest tube drainage following cardiac surgery Omaha, NE, July 26, 2022 — Centese, Inc. announces the first peer-reviewed...
View ArticleThoraguard Intelligent Chest Tube Management System Reduces Hospital Stay;...
New Peer-Reviewed Clinical Study Demonstrates Thoraguard® Advantages Over Conventional Analog Systems Following Lung Surgery OMAHA, Ne., September 13, 2022—Centese, Inc. announces the results of a...
View ArticleCentese, Inc. Secures Series B Funding and Strengthens Board With New Director
Company secures funding to fuel expansion of its Thoraguard® System; adds veteran medtech leader Timothy Still to Board of Directors Centese, Inc., a leader in digital surgery technology, announces...
View Article
